Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India flag India · Delayed Price · Currency is INR
58.80
-0.82 (-1.38%)
Nov 11, 2026, 2:30 PM IST

NSE:KREBSBIO Statistics

Total Valuation

NSE:KREBSBIO has a market cap or net worth of INR 1.25 billion. The enterprise value is 3.52 billion.

Market Cap1.25B
Enterprise Value 3.52B

Important Dates

The next estimated earnings date is Monday, February 8, 2027.

Earnings Date Feb 8, 2027
Ex-Dividend Date n/a

Share Statistics

Current Share Class 21.56M
Shares Outstanding n/a
Shares Change (YoY) -0.02%
Shares Change (QoQ) -0.06%
Owned by Insiders (%) 26.71%
Owned by Institutions (%) 0.00%
Float 4.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.71
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 170.90
P/OCF Ratio 45.96
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 13.16
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 477.34

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA 4,567.11
Debt / FCF 306.61
Interest Coverage -0.82

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -2.36%
Return on Invested Capital (ROIC) -6.52%
Return on Capital Employed (ROCE) -18.79%
Weighted Average Cost of Capital (WACC) 4.97%
Revenue Per Employee 1.89M
Profits Per Employee -940,092
Employee Count142
Asset Turnover 0.16
Inventory Turnover 0.55

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.54% in the last 52 weeks. The beta is 0.90, so NSE:KREBSBIO's price volatility has been similar to the market average.

Beta (5Y) 0.90
52-Week Price Change -12.54%
50-Day Moving Average 57.82
200-Day Moving Average 57.64
Relative Strength Index (RSI) 52.05
Average Volume (20 Days) 19,782

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:KREBSBIO had revenue of INR 268.57 million and -133.49 million in losses. Loss per share was -6.19.

Revenue268.57M
Gross Profit 241.21M
Operating Income -61.60M
Pretax Income -133.49M
Net Income -133.49M
EBITDA 497,000
EBIT -61.60M
Loss Per Share -6.19
Full Income Statement

Balance Sheet

The company has 1.26 million in cash and 2.27 billion in debt, with a net cash position of -2.27 billion.

Cash & Cash Equivalents 1.26M
Total Debt 2.27B
Net Cash -2.27B
Net Cash Per Share n/a
Equity (Book Value) -1.71B
Book Value Per Share -79.02
Working Capital -1.18B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.53 million and capital expenditures -20.13 million, giving a free cash flow of 7.40 million.

Operating Cash Flow 27.53M
Capital Expenditures -20.13M
Depreciation & Amortization 62.10M
Net Borrowing 75.50M
Free Cash Flow 7.40M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 89.81%, with operating and profit margins of -22.94% and -49.70%.

Gross Margin 89.81%
Operating Margin -22.94%
Pretax Margin -49.70%
Profit Margin -49.70%
EBITDA Margin 0.19%
EBIT Margin -22.94%
FCF Margin 2.76%

Dividends & Yields

NSE:KREBSBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 0.02%
Shareholder Yield 0.02%
Earnings Yield -10.53%
FCF Yield 0.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5